WHO ICTRP trial
Exercise during CHemotherapy for Recurrent Ovarian cancer (ECHO-R)
ACTRN12621000042842 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Recruiting
Key facts
| Trial ID | ACTRN12621000042842 |
|---|---|
| Public title | Exercise during CHemotherapy for Recurrent Ovarian cancer (ECHO-R) |
| Scientific title | A Phase II trial evaluating feasibility, safety and efficacy of an individually-tailored exercise intervention during chemotherapy for recurrent ovarian cancer (ECHO-R) |
| Primary sponsor | Griffith University |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | Australia |
| Conditions | Recurrent Ovarian Cancer; Recurrent Ovarian Cancer;Cancer - Ovarian and primary peritoneal |
| Interventions | Exercise intervention: The intervention will span 6 months and involve the individual prescription of aerobic and resistance-based exercise, with a dosage target of at least 150 minutes per week at moderate-intensity (moderate intensity =… |
| Registration date | Jan 18, 2021 |
| Target size | 80 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: